The global antibiotics market is expected to exhibit a solid 8.85% CAGR over the forecast period from 2020 to 2030, according to the latest research report from Market Research Future (MRFR). According to the report, the global antibiotics market was valued at more than USD 51.8 billion in 2018. The report presents a detailed look at the market’s historical growth trajectory and presents forecasts regarding the market’s growth prospects over the forecast period. The leading drivers and restraints affecting the global antibiotics market are studied in detail in the report, providing readers with a clear overview of the major factors affecting the market.

Antibiotics are medications that kill microbes. The growing prevalence of communicable diseases around the world is the major driver for the global antibiotics market. Communicable diseases caused by microbial pathogens include deadly diseases such as typhoid and malaria, leading to the healthcare sector taking huge steps to counter the threat of these diseases. The development of antibiotics has been a major step in the direction of eradicating these and other pathogenic diseases. Antibiotics were discovered in the mid-20^th century, when penicillin was discovered. This led to the discovery and creation of other antibiotics, leading to widespread usage of the same in healthcare applications.

Supportive government initiatives and regulations in recent years have driven the global antibiotics market. Acts such as the Generating Antibiotics Incentives Now (GAIN) Act have been major drivers for the global antibiotics market. The development of antibiotics is increasingly being supported by governments around the world, leading to smooth growth of the antibiotics market. This is likely to remain a major driver for the global antibiotics market over the forecast period.

Request Free Sample Copy at:

https://www.marketresearchfuture.com/sample_request/8447

Competitive Analysis:

Leading players in the global antibiotics market include Pfizer Inc., Johnson & Johnson Services Inc., Abbott Laboratories, GSK plc, Sanofi, Novartis AG, Bayer AG, Bristol-Myers Squibb Company, Eli Lilly and Company, Astellas Pharma Inc., Merck & Co. Inc., and F. Hoffman-La Roche Ltd. Major players in the global antibiotics market are likely to focus on product development in the coming years, as the increasing prevalence of coronavirus has created a strong need for effective antibiotics. The rising prevalence of coronavirus is likely to remain a key driver for the antibiotics market, as this is likely to lead to strong investment in research and development channels for the development of new antibiotics. The continued presence of coronavirus in the world is likely to remain a major driver for the global antibiotics market over the forecast period.

Segmentation:

The global antibiotics market is segmented on the basis of drug class, spectrum, drug origin, end use, and region.

By drug class, the global antibiotics market is segmented into cephalosporins, penicillin, fluoroquinolones, macrolides, carbapenem, aminoglycosides, sulfonamides, and others. The cephalosporins segment is expected to grow at the highest growth rate over the forecast period due to its use in treating urinary tract infections and pneumonia-like conditions. Carbapenems are also likely to exhibit steady growth over the forecast period.

By spectrum, the global antibiotics market is segmented into broad-spectrum and narrow-spectrum antibiotics. Broad-spectrum antibiotics such as cephalosporins and quinolones are likely to dominate the global antibiotics market in the coming years due to their applicability in the treatment of various kinds of diseases.

By drug origin, the global antibiotics market is segmented into natural, semi-synthetic, and synthetic. Natural is the largest segment of the antibiotics market and is likely to remain the largest over the forecast period. Semi-synthetic antibiotics are likely to grow at the highest growth rate over the forecast period.

By end use, the global antibiotics market is segmented into hospitals and clinics, research organizations, and others.

Regional Analysis:

The Americas remain the largest regional segment of the global antibiotics market due to the strong investment in the pharmaceutical sector. Growing development of innovative antibiotics and the growing government support to the development of antibiotics are also major drivers for the antibiotics market in North America. The U.S. is likely to remain the major regional segment for the global antibiotics market.

Browse Detailed TOC with COVID-19 Impact Analysis at:

https://www.marketresearchfuture.com/reports/antibiotics-market-8447

Browse More Related Report:

Medical Billing Market

https://www.marketresearchfuture.com/reports/medical-billing-market-1023

Cardiovascular Ultrasound Market

https://www.marketresearchfuture.com/reports/cardiovascular-ultrasound-market-1548

Contraceptive Pills Market

https://www.marketresearchfuture.com/reports/contraceptive-pills-market-2122

Alzheimer’s disease Diagnostics Market

https://www.marketresearchfuture.com/reports/alzheimers-disease-diagnostic-market-2149

Hernia Repair Market

https://www.marketresearchfuture.com/reports/hernia-repair-market-2287

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com